I currently own WELL, however I'm looking at at three others in the space, Vitalhub, cloudMD and Think Research.
Please give me an over view of the differentiation between these four.
Also your view, rank, on which of the four will be the best in 5 yrs.
Thx
Q: what are the differences between the services provided by THNK and WELL ? if there are many similarities will THNK compete with WELL in the future acquisition of companies in the digital and non digital field ? thanks Richard
Q: Any particular reason for the recent resurgence in Endo? It hit a new 52 week high today. Would this make it easier or harder for a potential purchase of the Paladin unit by Knight?
Q: I own XHC in a registered account. No heathcare in my non-registered account, looking to pick up 2-4% position. GUD and WELL have lots of info in the reports, similar comments on cash and acqisition strategy but the charts are very different. What one would you prefer for 4% or 2% each? Any others that I should consider / review?
Thanks,
Travis
Q: I am looking to increase my US exposure to the healthcare sector for my TSFA, which would you recommend TDOC or VEEV for growth potential, risk is not a factor? If you have other preferences, please include your list.
Q: We purchased ARCT at $105 US and it has dropped 50% due to underwhelming results.
It jumped 10% yesterday. Should we consider dollar cost averaging?
How would you rank the vaccine stocks in terms of growth?
Thanks for a great year.
Q: AstraZeneca has approval for its vaccine which apparently has easier storage and transportability than its competitors vaccines. Also will be cheaper and therefore more available to the third world.
Your thoughts please on this company as an investment; they are of course involved in many other pharmaceuticals than just vaccines.
Many thanks
Happy New Year
Peter
Q: I have to trim a couple percent from healthcare. Can you please rank your order of preference for the above mentioned stocks? Would you sell one or balance the 5? Thanks
Q: I have these 4 stocks, purchased higher than they are trading now, is there any hope they will go back up or should I just sell at a loss and take the hit? I was wondering if they may go back up with good earnings?
Q: Peter and Team:
I need some exposure to the healthcare sector and my choices are very limited in Canada, especially when Johnathon doesn't want to play in the Chess Game presently. What are your favourite US names, and where does ABBVIE fit in to the puzzle? When I am typing a question, does it time out after so many minutes?
Regards,
Ben.